A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)
Trial details
- Registry ID
- NCT07156578
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as LB54640
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)NCT07156578 | RYTM | Phase 2 | Enrolling by invitation | 2028-04-15Estimated |
| A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic ObesityNCT06046443 | RYTM | Phase 2 | Completed | 2026-02-09Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |